Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
AstraZeneca
US Army
Covington
Citi
Federal Trade Commission
Fuji
Boehringer Ingelheim

Generated: April 24, 2018

DrugPatentWatch Database Preview

DOXERCALCIFEROL Drug Profile

« Back to Dashboard

When do Doxercalciferol patents expire, and when can generic versions of Doxercalciferol launch?

Doxercalciferol is a drug marketed by Rising Pharms Inc, West-ward Pharms Int, Akorn Inc, Amneal Pharms Co, Hikma Pharms, and Sandoz Inc. and is included in eight NDAs.

The generic ingredient in DOXERCALCIFEROL is doxercalciferol. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the doxercalciferol profile page.
Drug patent expirations by year for DOXERCALCIFEROL
Pharmacology for DOXERCALCIFEROL
Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog
Synonyms for DOXERCALCIFEROL
(1|A,3|A,5Z,7E,22E)- 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7?-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7alpha-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
(1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
(5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3-diol
(5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol
1-alpha-hydroxyergocalciferol
1-alpha-Hydroxyvitamin D2
1-Hydroxyergocalciferol
1-Hydroxyvitamin D2
1?Hydroxy VitaMin D2
1|A-Hydroxy Vitamin D2
1|A-Hydroxyergocalciferol
1|A-Hydroxyvitamin D2
125285-48-5
1alpha-hydroxy vitamin D2
1alpha-Hydroxyergocalciferol
1alpha-hydroxyvitamin D2
1alpha-hydroxyvitamin D2 / 1alpha-hydroxyergocalciferol
1alpha-OH-D2
1alpha-OHD2
1alphaOHD2
3DIZ9LF5Y9
42163-EP2298768A1
42163-EP2311808A1
42163-EP2311829A1
54573-75-0
573D750
87649-67-0
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5Z,7E,22E)
AC1NQY15
ACT06836
AKOS005146517
BCI-101
BRN 4716774
C08211
C28H44O2
CAS-54573-75-0
CHEBI:4712
CHEMBL1200810
CS-0395
D01009
D0G5CF
Doxcercalciferol
Doxercalciferol (INN)
Doxercalciferol [INN]
Doxercalciferol [USAN:INN]
Doxercalciferol, >=98% (HPLC), solubility: >10 mg/mL in DMSO
Doxercalciferol, United States Pharmacopeia (USP) Reference Standard
DSSTox_CID_14214
DSSTox_GSID_34214
DSSTox_RID_79125
DTXSID1034214
GTPL2790
Hectorol
Hectorol (TN)
HKXBNHCUPKIYDM-CGMHZMFXSA-N
HSCI1_000341
HY-32348
LMST03010028
LS-144720
MFCD00871065
MolPort-018-493-676
NCGC00182058-03
OR009085
PubChem18823
SC-77181
SCHEMBL322422
Tox21_112978
TSA 840
UNII-3DIZ9LF5Y9
V1826
Vitamin D2, 1alpha-Hydroxy-
W-5181
ZINC4641374

US Patents and Regulatory Information for DOXERCALCIFEROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising Pharms Inc DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 201518-001 Sep 9, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn Inc DOXERCALCIFEROL doxercalciferol INJECTABLE;INJECTION 203929-002 Mar 28, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 091433-001 Sep 23, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharms DOXERCALCIFEROL doxercalciferol INJECTABLE;INJECTION 091101-001 Aug 30, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Baxter
Queensland Health
Citi
McKinsey
Chinese Patent Office
Farmers Insurance
Accenture
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.